CN Patent

CN102171202A — 用于治疗癌症的作为wnt信号通路抑制剂的基于吡啶和嘧啶的化合物

Assigned to Cancer Research Technology Ltd · Expires 2011-08-31 · 15y expired

What this patent protects

本发明涉及基于吡啶和嘧啶的化合物、包含这些化合物的药物组合物以及它们作为治疗和/或预防癌症的治疗剂的潜在用途。

USPTO Abstract

本发明涉及基于吡啶和嘧啶的化合物、包含这些化合物的药物组合物以及它们作为治疗和/或预防癌症的治疗剂的潜在用途。

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN102171202A
Jurisdiction: CN
Classification: —
Expires: 2011-08-31
Drug substance claim: No
Drug product claim: No
Assignee: Cancer Research Technology Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.